Taojing Life Co., Ltd.

Announcement on Acceptance of Medical Device Registration Application

Announcement on the re-certification of the holding subsidiary as a high-tech enterprise

Announcement of Implementation of 2025 Annual Equity Distribution

Announcement on Obtaining Invention Patent Certificate

Announcement of the Resolution of the 2025 Annual Shareholders' Meeting

Legal Opinion from Shanghai Guangda Law Firm on the 2025 Annual Shareholders' Meeting of Shanghai Toujing Life Science Technology Co., Ltd.

Announcement on the release and pledge of shares by shareholders holding more than 5%

Announcement on the Proposed Reappointment of the Audit Institution for 2026

2026 Non-independent Director Compensation Plan

2025 Annual Board of Directors Work Report

2026 Senior Management Compensation Plan

2025 Annual Independent Director Work Report (Zhao Jiaxiang)

2025 Annual Independent Director Work Report (Chen Shaoxiong)

2025 Annual Independent Director Work Report (Yu Wei)

Announcement on Participation in the 2026 Annual Report Collective Performance Presentation Meeting for Listed Companies in Shanghai

Internal Control Audit Report of Shanghai Toukeng Life Science Technology Co., Ltd. (2025)

2025 Annual Internal Control Self-assessment Report

Internal Information Reporting System (Revised April 2026)

Amendment to the Articles of Association of Shanghai Toukeng Life Science Technology Co., Ltd. (April 2026)

Management System for Director and Senior Management Compensation (Allowances)

Reminder Announcement on the Disclosure of the 2025 Annual Report and the Q1 2026 Report

Announcement on the Repurchase and Cancellation of Part of the Restricted Stocks Granted to Incentive Objects but Not Yet Released from Restrictions, Notifying Creditors

Announcement on Changing Registered Capital and Amending the Articles of Association

Announcement on the Provision for Asset Impairment for the Year 2025

Legal Opinion from Shanghai Guangfa Law Firm on Matters Related to the Stock Option and Restricted Stock Incentive Plan of Shanghai Toukeng Life Science Technology Co., Ltd. for 2023

Verification Opinion from the Compensation and Assessment Committee of the Board of Directors on the List and Quantity of Subjects Involved in the Cancellation of Stock Options and Repurchase of Restricted Stocks

Announcement on the Cancellation of Part of the Stock Options and the Repurchase and Cancellation of Part of the Restricted Stocks

Announcement on the Confirmation of Daily Related Transactions for 2025 and the Estimated Daily Related Transactions for 2026

Notice of the 2025 Annual Shareholders' Meeting

Announcement on the Resolutions of the 16th Meeting of the 4th Board of Directors

Announcement on Proposing the Shareholders' Meeting to Authorize the Board of Directors to Formulate and Implement the Mid-term Profit Distribution Plan for 2026

Announcement on the Profit Distribution Plan for 2025

Q1 2026 Report

Special Audit Report on the Performance Commitment and Accounts Receivable Recovery Commitment of Wuhan Kanglu Biotechnology Co., Ltd. for 2025

Verification Report on the Deduction of Operating Income for Shanghai Toukeng Life Science Technology Co., Ltd. for 2025

2025 Annual Assessment Report on the Performance of the Accounting Firm

Report by the Board Audit Committee on the Evaluation of the Accounting Firm's Performance in 2025 and Supervision Responsibilities

Special Report on Non-operating Fund Occupation and Other Related Fund Transactions by Shanghai Toukeng Life Science Technology Co., Ltd. (2025)

Summary Table of Non-operating Fund Occupation and Other Related Fund Transactions for 2025

Board Special Opinion on the Independence of Independent Directors

2025 Annual Audit Report

2025 Annual Report

2025 Annual Report Summary

Announcement on the Company's Use of Idle Self-owned Funds for Entrusted Wealth Management

Announcement on Requesting Shareholder Authorization for the Board to Handle Small Quick Financing Matters

Announcement on the Acquisition of Partial Equity in a Controlling Subsidiary and Related Transactions

Announcement on Wholly-Owned Subsidiaries Passing the Re-certification as High-Tech Enterprises

Announcement on Changes in Registered Capital and Completion of Industrial and Commercial Change Registration

Announcement Regarding Wholly-Owned Subsidiary Obtaining Medical Device Registration Certificate